| Financial Year |
March 31 2023 |
| Monetary Funds |
5,248,087,879.13 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
63,086,056.41 |
| Accounts Receivable |
4,270,916,736.98 |
| Advances to Suppliers |
1,815,174,122.20 |
| Other Receivables |
384,095,843.99 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,014,800,062.32 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,012,737,685.94 |
| Other Current Assets |
176,929,697.85 |
| Total Current Assets |
14,630,749,338.87 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,839,009,864.76 |
| Long-term Equity Investment |
1,311,542,322.21 |
| Investment Properties |
15,163,887.15 |
| Fixed Assetes |
2,732,617,522.72 |
| Under-construction Projects |
12,965,875.43 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,568,824,827.60 |
| R&D expenses |
-- |
| Goodwill |
14,150,171.45 |
| Long-Term Deferred and Prepaid Expenses |
10,865,365.74 |
| Deferred Income Tax Assets |
154,270,770.94 |
| Other Non-Current Assets |
154,581,997.48 |
| Sub-Total of Non-Current Assets |
8,263,202,846.54 |
| Total Assets |
22,893,952,185.41 |
| Short-Term Loans |
758,540,417.57 |
| Trading Financial liabilities |
1,763,789.27 |
| Notes Payable |
1,338,995,740.53 |
| Accounts Payable |
5,303,888,930.91 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
90,819,734.21 |
| Taxes Payable |
277,541,377.28 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
193,169,979.81 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,228,042.81 |
| Other Current Liabilities |
38,717,071.55 |
| Sub-Total of Current Liabilities |
9,268,025,487.06 |
| Long-term Loans |
4,301,784,705.93 |
| Bonds Payable |
483,645,913.51 |
| Long-Term Accounts Payable |
73,084,740.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
11,985,738.80 |
| Deferred Income Tax Liabilities |
32,199,451.52 |
| Other Non-Current Liabilities |
2,160,214.37 |
| Sub-Total of Non-Current Liabilities |
4,945,448,991.10 |
| Total Liabilities |
14,213,474,478.16 |
| Paid-In Capital(Or Share Stock) |
1,001,747,626.00 |
| Capital Surplus |
1,892,617,938.86 |
| Surplus Reserve |
351,610,713.23 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
4,734,797,832.60 |
| Minority Stockholder's Interest |
817,656,612.59 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,862,821,094.66 |
| Owner's Equity（Stockholder's Equity） |
8,680,477,707.25 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
22,893,952,185.41 |
